Tetra Bio-Pharma (OTC: TBPMF) Announces Start of the REBORN1(C) Clinical Trial
First ever Phase 2 clinical trial designed to evaluate the effect of cannabis against an opioid treatment QIXLEEF™ has the potential to transform the pain market OTTAWA, ON / May 6, 2021 / Tetra Bio-Pharma […]
